# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Bardet-Biedl Syndrome

Laurence-Moon-Bardet-Biedl syndromeLaurence-Moon syndrome
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-5 of 5 results.
Clinical Registry Investigating Bardet-Biedl Syndrome
Status: Recruiting
Last Changed: Nov 01, 2018
First Received: Dec 31, 2014
Disease(s): Bardet-Biedl Syndrome
Locations: Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
Status: Recruiting
Last Changed: Dec 12, 2019
First Received: Nov 19, 2018
Disease(s): Bardet Biedl Syndrome (BBS), Alström Syndrome (AS)
Intervention(s): Setmelanotide, Placebos
Locations: Wr-McCr, Llc, San Diego, California, United States
UMMS Baystate Health; BAYSTATE MEDICAL CENTER; Baystate Children's Specialty Center, Springfield, Massachusetts, United States
Columbia University Center, New York, New York, United States
M3 Wake Research, Raleigh, North Carolina, United States
University of Tennessee Health Science Center, Memphis, Tennessee, United States
... and 9 other locations.
Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Status: Recruiting
Last Changed: Sep 19, 2019
First Received: Jan 06, 2017
Disease(s): Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Bardet-Biedl Syndrome, Alstrom Syndrome, Smith-Magenis Syndrome
Intervention(s): Setmelanotide
Locations: Honor Health Research Institute, Scottsdale, Arizona, United States
Axis Clinical Trials Headquarters, Los Angeles, California, United States
Axis Clinical Trials-Downtown, Los Angeles, California, United States
University of Colorado Hospital, Aurora, Colorado, United States
University of Florida College of Medicine, Gainesville, Florida, United States
... and 19 other locations.
Inherited Retinal Degenerative Disease Registry
Status: Recruiting
Last Changed: Dec 13, 2018
First Received: May 06, 2015
Disease(s): Eye Diseases Hereditary, Retinal Disease, Achromatopsia, Bardet-Biedl Syndrome, Bassen-Kornzweig Syndrome, Batten Disease, Best Disease, Choroidal Dystrophy, Choroideremia, Cone Dystrophy, Cone-Rod Dystrophy, Congenital Stationary Night Blindness, Enhanced S-Cone Syndrome, Fundus Albipunctatus, Goldmann-Favre Syndrome, Gyrate Atrophy, Juvenile Macular Degeneration, Kearns-Sayre Syndrome, Leber Congenital Amaurosis, Refsum Syndrome, Retinitis Pigmentosa, Retinitis Punctata Albescens, Retinoschisis, Rod-Cone Dystrophy, Rod Dystrophy, Rod Monochromacy, Stargardt Disease, Usher Syndrome
Locations: Foundation Fighting Blindness, Columbia, Maryland, United States
UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Status: Recruiting
Last Changed: Oct 25, 2019
First Received: Jul 26, 2011
Disease(s): Hepato/Renal Fibrocystic Disease, Autosomal Recessive Polycystic Kidney Disease, Joubert Syndrome, Bardet Biedl Syndrome, Meckel-Gruber Syndrome, Congenital Hepatic Fibrosis, Caroli Syndrome, Oro-Facial-Digital Syndrome Type I, Nephronophthisis, Glomerulocystic Kidney Disease
Locations: Children's National Health System, Washington, District of Columbia, United States